PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2010; 5(8): e12198.
Published online 2010 August 16. doi:  10.1371/journal.pone.0012198
PMCID: PMC2922374

Increased Genetic Diversity of HIV-1 Circulating in Hong Kong

Vladimir N. Uversky, Editor

Abstract

HIV-1 group M strains are characterized into 9 pure subtypes and 48 circulating recombinant forms (CRFs). Recent studies have identified the presence of new HIV-1 recombinants in Hong Kong and their complexity continues to increase. This study aims to characterize the HIV-1 genetic diversity in Hong Kong. Phylogenetic analyses were performed by using HIV-1 pol sequences including protease and partial reverse transcriptase isolated from 1045 local patients in Hong Kong from 2003 to 2008. For the pol sequences with unassigned genotype, the evidence of recombination was determined by using sliding-window based bootscan plots and their env C2V3 region were also sequenced. Epidemiological background of these patients was further collected. The pol phylogenetic analyses highlighted the extent of HIV-1 genetic diversity in Hong Kong. Subtype B (450/1045; 43.1%) and CRF01_AE (469/1045; 44.9%) variants were clearly predominant. Other genotypes (126/1045; 12.1%) including 3 defined subtypes, 10 CRFs, 1 unassigned subtype and 33 recombinants with 11 different mosaic patterns were observed. Recombinants of subtype B and CRF01_AE were mainly found among local Chinese MSM throughout 2004 to 2008, while the CRF02_AG and subtype G recombinants were circulating among non-Chinese Asian population in Hong Kong through heterosexual transmission starting from 2008. Our study demonstrated the complex recombination of HIV-1 in Hong Kong and the need in developing surveillance system for tracking the distribution of new HIV-1 genetic variants.

Introduction

Human immunodeficiency virus (HIV) carries an error prone reverse transcriptase which causes its extraordinary genetic diversity [1]. Throughout the epidemic, 9 subtypes (A–D, F–H, J and K) and a further 48 major circulating recombinant forms (CRFs) has been documented within HIV type 1 (HIV-1) M group (http://www.hiv.lanl.gov/content/hiv-db/CRFs/CRFs.html). Genetic founder effect causes the heterogeneous and specific global geographic distribution of different HIV-1 group M strains [2]. HIV-1 subtype C infection is predominant in the world while the epidemic in the western world is primarily caused by HIV-1 subtype B variants [3]. In the East and Southeast Asia, CRF01_AE is highly predominant.

Meanwhile, the frequent self-recombination and ongoing exchange of HIV-1 strains between geographic regions through population migration and travel caused a small number of group M strains to move into new host populations [2]. In recent years, growing numbers of HIV-1 recombinant forms have been identified in different geographical regions [2]. The CRF01_AE, CRF07_BC, CRF08_BC, CRF33_01B and CRF34_01B were confirmed to be originated in Asia while new unique recombinant forms (URFs) are continually being identified in these years and their complexity continues to increase [4], [5], [6]. These URFs may later become new CRFs after circulating in particular geographical areas.

Up to the end of 2006, the HIV-1 subtype B (36.4%) and CRF01_AE (48.8%) are co-predominant in Hong Kong [7], [8]. Through phylogenetic estimation, the divergence date of these strains in Hong Kong is around 1995–2001 [9], [10]. However, the prevalence of other new recombinant forms in Hong Kong remains unclear. Hong Kong is a metropolitan city located at the centre of the Southeast Asia. The high migration and traveling population of Hong Kong with other HIV-1 epidemic Asian countries such as Mainland China, Thailand, India, Malaysia, etc. may enhance the development of new HIV-1 recombinants in the Southeast Asia.

As the rising number of new recombinant lineages can significantly impact therapeutics and vaccine development [11], [12], this study aims to investigate the prevalence and characterization of new recombinants circulating in Hong Kong from 2003 to 2008. Also, we would like to track the epidemiological transmission reservoir of these recombination variants.

Results

Distribution of HIV-1 group M variants in Hong Kong

The 1045 individuals were recruited in the Integrated Treatment Centre of the Department of Health from January 2003 to December 2008 which represented 51.4% (1045/2032) of all new diagnoses of HIV-1 infection in Hong Kong within that period of time (available at http://www.info.gov.hk/aids). The pol phylogenetic analysis could assign confident genotypes to 96.3% of samples (1006/1045), while subtype B and CRF01_AE accounted for 43.1% (450/1045) and 44.9% (469/1045) of the total number of samples respectively. HIV-1 variants with other genotypes were recognized in 12.1% of samples (126/1045) including subtype A1 (1/126; 0.8%), C (44/126; 34.9%), D (1/126; 0.8%), CRF02_AG (7/126; 5.6%), CRF03_AB (2/126; 1.6%), CRF06_cpx (1/126; 0.8%), CRF07_BC (20/126; 15.9%), CRF08_BC (9/126; 7.1%), CRF15_01B (2/126; 1.6%), CRF22_01A1 (1/126; 0.8%), CRF33_01B (2/126; 0.8%), CRF42_02G (1/126; 0.8%) and CRF43_02G (1/126; 0.8%). There were another 34 samples (34/126; 27.0%) that could not be confidently assigned to previously defined subtypes or CRFs by the pol phylogenetic analysis (Figure 1a).

Figure 1
Phylogenetic relationships of 34 unassigned pol gene sequences (1a) and 31 unassigned env gene C2V3 region sequences (1b).

The env C2V3 region of the 34 unassigned samples were further sequenced and confidently assigned genotypes (bootstrap value >70) could only be found on 31 samples in the env phylogenetic tree (Figure 1b) and 3 samples were failed in the env gene PCR-sequencing. There was no genetic recombination found in any of the 31 available env sequences while 1 sample was genotyped as subtype F2-like outgroup by using pol gene and CRF02_AG by using env gene (Table 1).

Table 1
The pol and env genotype of the 34 unassigned genotype samples.

Through the bootscanning recombination analysis, 33 out of the 34 unassigned samples were found to have genetic recombination in the pol gene and another one was classified as unassigned subtype F2 (UF2). The bootscanning recombination patterns were shown in Figure 2. Samples with subtype B and CRF01_AE recombination in the pol region were identified in 16 samples with different recombination patterns (UB/CRF01(a), UB/CRF01(b) and UCRF01/B). Recombination of subtype G and CRF02_AG in the pol gene (UG/CRF02) were identified in another 5 samples. Three samples were found to have subtype B and subtype C recombination in the pol region with 2 different recombination patterns (UB/C and UC/B), while another 3 samples were CRF01_AE and subtype C recombinants (UCRF01/C). Recombination of CRF02_AG and subtype K (UCRF02/K) (2 samples), CRF02_AG and CRF01_AE (UCRF02/CRF01 and UCRF01/CRF02) (2 samples), and CRF03_AB and A1 (UCRF03/A1) (2 samples) were also observed.

Figure 2
Bootscanning plots of the unassigned pol gene variants.

Characteristics of new recombinant infected patients

The first recombinant sample in this study was collected in 2004 and the number of cases increased progressively in the following years (Table 2).

Table 2
The epidemiological background of the 33 genotype unassigned recombinants.

The UB/CRF01 recombinant was the only recombination variant that was found every year between 2004 and 2008, while almost all these samples were collected from Hong Kong Chinese male residents (13 out of 14). The transmission route among these Chinese males was found to be MSM (9 samples) and heterosexual (3 samples) transmission. Another sample was isolated from a male Vietnamese immigrant with intravenous drug use. For the UCRF01/B recombinant, it was isolated from a Chinese heterosexual male and a Filipino female. The Filipino female was confirmed catching disease through heterosexual transmission.

Another 5 UG/CRF02 recombinant cases were all isolated in 2008. This recombinant variant infected 2 non-Chinese male patients including 1 African from Ghana and 1 Bangladeshi. The other 3 patients were non-Chinese Asian females from Indonesia (1 patient) and the Philippines (2 patients). All 5 patients arrived in Hong Kong since 2006 with HIV infection through heterosexual transmission between 2007 and 2008.

Recombinant of subtype B and C (UB/C and UC/B) were isolated from 3 Chinese males. The UC/B infected patient was confirmed catching HIV-1 away from Hong Kong through heterosexual transmission.

The UCRF01/C recombinants were identified in 3 heterosexual patients including 1 Chinese female, 1 Nepalese male and 1 Nepalese female. The two Nepalese were husband and wife while the wife had been confirmed to catch disease from the male patient.

For the UCRF02/K recombinants, cases were reported in 2007 and 2008 which samples were collected from 1 Nigerian male and 1 Filipino female.

The UCRF03/A1 recombinant was identified in another 2 patients who got infection through heterosexual transmission (1 Chinese male and 1 British Caucasian male) while the UCRF02/CRF01 recombinant was identified in one Nigerian female and the UCRF02/CRF01 recombinant was found in one Chinese male.

Discussion

Prior HIV-1 molecular epidemiology studies performed in Asia were mainly focused on the transmission of locally predominant HIV-1 genotypes [7], [10], [13], [14]. There was limited number of studies which focused on new HIV-1 group M recombinant transmission. In this study, we demonstrated the broad HIV-1 genetic diversity in Hong Kong and it is the first comprehensive study in Asia revealing the transmission of different new recombinants in the same locality.

The treatment naïve HIV-1 samples in this study were collected from 2003 to 2008 in Hong Kong and the study cohort herein was estimated to represent about 50% of the total HIV-1 patients in Hong Kong within the 5 years [15]. Among the total HIV-1 patients in Hong Kong, about 60–70% of them were local Chinese inhabitants, while the other 30–40% of patients was non-Chinese residents including non-Chinese Asians, Caucasians and Africans. From the large sample size included in this study, we can further confirm that subtype B (43.1%) and CRF01_AE (44.9%) were co-dominant HIV-1 genotypes among the local Chinese patients in Hong Kong. This genotyping distribution showed complete concordance to our recent studies [7], [10]. Other than these two predominant genotypes, another 12 defined subtypes or CRFs were also identified, while subtype C and CRF07_BC were more commonly found. Other defined HIV-1 CRFs, such as CRF22_01A1, CRF42_02G and CRF43_02G were sporadically found in Hong Kong and these CRFs are first ever reported in Hong Kong and China. This broad range of defined HIV-1 genotypes suggested the multiple route of transmission for the import of new HIV-1 genotypes into the Hong Kong local population.

On the other hand, our study also revealed the circulation of certain number of new HIV-1 recombinants among local HIV-1 patients in Hong Kong while the total number of HIV-1 infection is low throughout the past 10 years. Through the bootscanning recombinant analysis, 11 different mosaic pol genotypic patterns were found among the 33 unassigned recombinant samples. The UB/CRF01 and UG/CRF02 recombinant were further found to have local transmission among the Chinese MSM and the non-Chinese population in Hong Kong respectively. The UB/CRF01 recombinant cases were identified every year from 2004 to 2008 which suggested a stable transmission route of the UB/CRF01 recombinant has been established among the local Chinese MSM population. The presence of the UB/CRF01 recombinant in this patient risk group suggested the support the “genetic founder effect” hypothesis of the recombination between local subtype B and CRF01_AE HIV strains. By comparing the mosaic fractions of the new UB/CRF01 recombinants with other Asian pol sequences, the new UB/CRF01 recombinant is 97% identical to the circulating local CRF01_AE or pure subtype B viruses in Hong Kong. This suggests that local subtype B and CRF01_AE were origins of the UB/CRF01 recombinant. Full viral genome sequencing will be done to elucidate the sequences of this new recombinant.

This study also identified 5 cases of UG/CRF02 recombinant infection within 5 months in 2008. The patients were all non-Chinese Asian and African who arrived to Hong Kong starting from 2006. They were estimated to catch HIV-1 infection through heterosexual transmission between 2007 and 2008. As subtype G and CRF02_AG were not commonly found in Hong Kong in the past 10 years, we believe this UG/CRF02 recombinant is not originated from the local circulating subtype G and CRF02_AG strains. Since the viral pol sequences of the 5 UG/CRF02 cases demonstrated a 98% similarity, it is plausible that there might be linkages between the sources of infection with this recombinant strain in these non-Chinese cases. Although this study could not prove the origin of this new UG/CRF02 recombinant, there is high possibility that the UG/CRF02 recombinant was imported to Hong Kong between 2007 and 2008 through non-Chinese HIV-1 carriers.

In conclusion, our study revealed the broad genetic diversity of HIV-1 in Hong Kong and identified two local spreading new recombinant lineages. Since the rising number of new recombinant lineages can significantly impact therapeutics and vaccine development, therefore, a good surveillance system for tracking the distribution of new HIV-1 genetic variants will be necessary.

Materials and Methods

Ethics approval has been obtained from the Institutional Review Board of the University of Hong Kong/Hospital Authority (Hong Kong West Cluster) with Reference number UW08-070.

Patient samples

This study included the first available plasma samples isolated from 1045 HIV-1 positive patients who had used the genotyping resistance testing service of the Department of Health between 2003 and 2008. All patient samples were reported to be treatment naïve at the moment of collection.

HIV sequencing and phylogenetic analysis

The HIV-1 pol sequences were amplified and sequenced by ViroSeq HIV-1 Genotyping System version 2.0 (Celera Diagnostics, CA) or an in-house genotyping method as described previously [8]. All the pol sequences incorporated entire protease (297 base pairs; 99 codons) and partial reverse transcriptase (828 base pairs; 276 codons) region, with a total length of 1125 base pairs. The HIV-1 genotypes were then determined by the phylogenetic analysis. The pol sequences were aligned with HIV-1 group M 2009 reference sequences in the NCBI Viral Genotyping Tool (http://www.ncbi.nlm.nih.gov/projects/genotyping) by using MUSCLE [16]. Phylogenetic tree was constructed with PAUP* 4.0 using the neighbor joining (NJ) algorithms with 1000 bootstrap replicates [17]. In order to determine the clade assignments and recombinant structure of the genotype unassigned sequences, bootscanning analyses were performed on the genotype unassigned samples with the SimPlot software [18]. The SimPlot performed bootscanning on neighbor-joining trees by using SEQBOOT, DNADIST, NEIGHBOR and CONSENSE from the PHYLIP package on a moving window of 300–400 base pairs along the alignment with 50 base pairs increments. The bootstrap values for the studied sequences were plotted at the midpoint of each window. In the analysis, the new sequences were compared with consensus sequences (50% threshold) representing the HIV-1 variants from the same alignment used for phylogenetic tree analysis.

Furthermore, the env C2V3 region of the unassigned samples were amplified and sequenced by 2 pairs of in-house primers (ENV1F 5′-TAGGCATCTCCTATGGCAGGAAGAAGCGG-3′; ENV1R 5′-CACTTCTCCAATTGTCYYTCATATYTCCTCCTCCAGG-3′; ENV2F 5′-ATACATTATTGTGCYCCRGCTGG-3′ and ENV2R 5′-ATGGGAGGGGCATAYATTGC-3′). The 480 base pair sequences were then aligned with env sequences of the NCBI HIV-1 2009 reference set.

Epidemiology data analysis

For determining the epidemiological transmission reservoir of the unassigned genotype samples, the patient epidemiological information including the age, gender, ethnicity, place of birth, route of transmission, plasma sampling date were collected from the Integrated Treatment Centre, Department of Health.

Acknowledgments

We would like to thank the Nursing Team of the Integrated Treatment Centre for their patient care and sample collection. We also thank Ms. Joanna Ip and Ms. Jane Kwok for their excellent technical assistance.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: The study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (Grant MSS-155R and MSS-164R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science. 1988;242:1171–1173. [PubMed]
2. McCutchan FE. Global epidemiology of HIV. J Med Virol. 2006;78(Suppl 1):S7–S12. [PubMed]
3. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20:W13–23. [PubMed]
4. Leitner T, Korber B, Daniels M, Calef C, Foley B. HIV-1 subtype and circulating recombinant form (CRF) reference sequences. Los Alamos: HIV Sequence Compendium; 2005.
5. Thomson MM, Najera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev. 2005;7:210–224. [PubMed]
6. Zhang Y, Lu L, Ba L, Liu L, Yang L, et al. Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med. 2006;3:e443. [PMC free article] [PubMed]
7. Leung TW, Mak D, Wong KH, Wang Y, Song YH, et al. Molecular epidemiology demonstrated three emerging clusters of human immunodeficiency virus type 1 subtype B infection in Hong Kong. AIDS Res Hum Retroviruses. 2008;24:903–910. [PubMed]
8. Chen JH, Wong KH, Chan K, Lam HY, Lee SS, et al. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping. J Clin Virol. 2007;39:125–131. [PubMed]
9. Chen JH, Wong KH, Chan KC, Lam HY, Yuen KY, et al. Molecular epidemiology and divergence of HIV type 1 protease codon 35 inserted strains among treatment-naive patients in Hong Kong. AIDS Res Hum Retroviruses. 2008;24:537–542. [PubMed]
10. Chen JH, Wong KH, Li P, Chan KC, Lee MP, et al. Molecular epidemiological study of HIV-1 CRF01_AE transmission in Hong Kong. J Acquir Immune Defic Syndr. 2009;51:530–535. [PubMed]
11. Gueudin M, Plantier JC, Lemee V, Schmitt MP, Chartier L, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007;44:500–505. [PubMed]
12. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med. 2008;358:1590–1602. [PMC free article] [PubMed]
13. Chen YJ, Huang YH, Chuang SY, Kao DY, Lan YC, et al. Molecular epidemiology of HIV-1 subtype B, CRF01_AE, and CRF07_BC infection among injection drug users in Taiwan. J Acquir Immune Defic Syndr. 2010;53:425–439. [PubMed]
14. Xiridou M, van Griensven F, Tappero JW, Martin M, Gurwith M, et al. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 2007;45:468–475. [PubMed]
15. Virtual AIDS Office of Hong Kong. 2009. Available: http://www/info.gov.hk/aids.
16. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797. [PMC free article] [PubMed]
17. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406–425. [PubMed]
18. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152–160. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science